Efficacy of original bacterial lysate in COPD affected by comorbidity: pharmacoeconomic aspect

Chronic obstructive pulmonary disease (COPD) is a common respiratory disease that is one of the major causes of disability and mortality of patients. Objective of the study: clinical, pharmacological and pharmacoeconomic study of the effect of oral bacterial lysate (BL) pathogens of respiratory tract infections on the duration of the stable course of COPD and hospitalization rate in patients with different risk factors and comorbidity the presence of chronic kidney disease (CKD) and cardiovascular disease (CVD). Methods of the study: clinical, pharmacological and statistical research methods: retrospective review of inpatients’ records, assessment of the patients’ quality of life, identifying subgroups of patients with cluster analysis, pharmacoeconomic doi: 10.21518/1561–5936–2019–11-47-52